alendronate has been researched along with Acute Myelogenous Leukemia in 1 studies
alendronic acid : A 1,1-bis(phosphonic acid) that is methanebis(phosphonic acid) in which the two methylene hydrogens are replaced by hydroxy and 3-aminopropyl groups.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Systemic mastocytosis is a rare and occasionally aggressive condition that raises major diagnostic challenges." | 1.32 | Aggressive systemic mastocytosis. ( Bertin, P; Inaoui, R; Jaccard, A; Petit, B; Trèves, R, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Inaoui, R | 1 |
| Petit, B | 1 |
| Jaccard, A | 1 |
| Bertin, P | 1 |
| Trèves, R | 1 |
1 other study available for alendronate and Acute Myelogenous Leukemia
| Article | Year |
|---|---|
Aggressive systemic mastocytosis.
Topics: Aged; Alendronate; Bone Marrow Cells; Fatal Outcome; Female; Humans; Interferon-alpha; Leukemia, Mye | 2003 |